Raich v. Ashcroft

352 F.3d 1222, 2003 U.S. App. LEXIS 25317, 2003 WL 22962231
CourtCourt of Appeals for the Ninth Circuit
DecidedDecember 16, 2003
Docket03-15481
StatusPublished
Cited by37 cases

This text of 352 F.3d 1222 (Raich v. Ashcroft) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Raich v. Ashcroft, 352 F.3d 1222, 2003 U.S. App. LEXIS 25317, 2003 WL 22962231 (9th Cir. 2003).

Opinions

[1224]*1224OPINION

PREGERSON, Circuit Judge:

Two of the appellants, Angel MeClary Raich and Diane Monson, are seriously ill Californians who use marijuana for medical purposes on the recommendation of their doctors. Such use is legal under California’s Compassionate Use Act. Mon-son grows her own medical marijuana. The remaining two appellants, John Doe Number One and John Doe Number Two, assist Raich in growing her marijuana. On October 9, 2002, the appellants filed suit against John Ashcroft, the Attorney General of the United States, and Asa Hutchinson, the Administrator of the Drug Enforcement Administration, seeking injunctive and declaratory relief based on the alleged uneonstitutionality of the federal Controlled Substances Act. The appellants also seek a declaration that the medical necessity defense precludes enforcement of that act against them.

On March 5, 2003, the district court denied the appellants’ motion for a preliminary injunction because the appellants had not established a sufficient likelihood of success on the merits. That ruling is now before us.

FACTUAL AND PROCEDURAL HISTORY

A. Statutory Scheme

1. The Controlled Substances Act

Congress enacted the Controlled Substances Act, 21 U.S.C. § 801 et seq., (“CSA”) as part of the Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub.L. 91-513, 84 Stat. 1236. The CSA establishes five “schedules” of certain drugs and other substances and designates these items “controlled substances.” 21 U.S.C. §§ 802(6), 812(a). Marijuana is a schedule I controlled substance. Id. § 812(c). For a drug or other substance to be designated a schedule I controlled substance, it must be found (1) that the substance “has a high potential for abuse”; (2) that the substance “has no currently accepted medical use in treatment in the United States”; and (3) that there is “a lack of accepted safety for use of the drug or other substance under medical supervision.” Id. at § 812(b)(1). The CSA sets forth procedures by which the schedules may be modified. Id. at § 811(a).

Among other things, the CSA makes it unlawful to knowingly or intentionally “manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance,” except as provided for in the statute. 21 U.S.C. § 841(a)(1). Possession of a controlled substance, except as authorized under the CSA, is also unlawful. Id. § 844(a).

Congress set forth certain findings and declarations in the CSA, the most relevant of which are as follows:

(2) The illegal importation, manufacture, distribution, and possession and improper use of controlled substances have a substantial and detrimental effect on the health and general welfare of the American people.
(4) Local distribution and possession of controlled substances contribute to swelling the interstate traffic in such substances.
(5) Controlled substances manufactured and distributed intrastate cannot be differentiated from controlled substances manufactured and distributed interstate. Thus, is it not feasible to distinguish, in terms of controls, between controlled substances manufactured and distributed interstate and controlled substances manufactured and distributed intrastate.
(6) Federal control of the intrastate incidents of the traffic in controlled sub[1225]*1225stances is essential to the effective control of the interstate incidents of such traffic.

21 U.S.C. § 801.

2. California’s Compassionate Use Act of 1996

In 1996, California voters passed Proposition 215, which is codified as the Compassionate Use Act of 1996 (“Compassionate Use Act”), Cal. Health & Safety Code § 11362.5. Among other purposes, the Compassionate Use Act is intended

[t]o ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the person’s health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.

Id. § 11362.5(b)(1)(A). The Compassionate Use Act is also intended “[t]o ensure that patients and their primary caregivers who obtain and use marijuana for medical purposes upon the recommendation of a physician are not subject to criminal prosecution or sanction.” Id. § 11362.5(b)(1)(B). To these ends, the Compassionate Use Act exempts “a patient, or [] a patient’s primary caregiver, who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician” from certain other California code sections that make possession or cultivation of marijuana illegal. Id. § 11362.5(d).

B. Factual Background

Appellants Angel McClary Raich and Diane Monson (the “patient-appellants”) axe California citizens who currently use marijuana as a medical treatment. Appellant Raich has been diagnosed with more than ten serious medical conditions, including an inoperable brain tumor, life-threatening weight loss, a seizure disorder, nausea, and several chronic pain disorders. Appellant Monson suffers from severe chronic back pain and constant, painful muscle spasms. Her doctor states that these symptoms are caused by a degenerative disease of the spine.

Raich has been using marijuana as a medication for over five years, every two waking hours of every day. Her doctor contends that Raich has tried essentially all other legal alternatives and all are either ineffective or result in intolerable side effects; her doctor has provided a list of thirty-five medications that fall into the latter category alone. Raich’s doctor states that foregoing marijuana treatment may be fatal. Monson has been using marijuana as a medication since 1999. Monson’s doctor also contends that alternative medications have been tried and are either ineffective or produce intolerable side effects. As the district court put it: “Traditional medicine has utterly failed these women.... ”

Appellant Monson cultivates her own marijuana. Raich is unable to cultivate her own. Instead, her two caregivers, appellants John Doe Number One and John Doe Number Two, grow it for her. These caregivers provide Raich with her marijuana free of charge. They have sued anonymously in order to protect Raich’s supply of medical marijuana. In growing marijuana for Raich, they allegedly use only soil, water, .nutrients, growing equipment, supplies and lumber -originating from or manufactured within California. Although these caregivers cultivate marijuana for Raich, she processes some of the marijuana into cannabis oils, balm, and foods.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Dugan
657 F.3d 998 (Ninth Circuit, 2011)
United States v. $186,416.00 in U.S. Currency
527 F. Supp. 2d 1103 (C.D. California, 2007)
Raich v. Gonzales
Ninth Circuit, 2007
United States v. Hedrick
146 F. App'x 871 (Ninth Circuit, 2005)
United States v. Avaloz
143 F. App'x 31 (Ninth Circuit, 2005)
Colorado v. Nord
377 F. Supp. 2d 945 (D. Colorado, 2005)
Haumant v. Griffin
699 N.W.2d 774 (Court of Appeals of Minnesota, 2005)
Gonzales v. Raich
545 U.S. 1 (Supreme Court, 2005)
United States v. Alvin Smith
459 F.3d 1276 (Eleventh Circuit, 2005)
United States v. Smith
402 F.3d 1303 (Eleventh Circuit, 2005)
United States v. Ortega-Amaro
126 F. App'x 369 (Ninth Circuit, 2005)
United States v. Herrick
118 F. App'x 339 (Ninth Circuit, 2005)
Washburn v. Columbia Forest Products, Inc.
104 P.3d 609 (Court of Appeals of Oregon, 2005)
United States v. Lane
116 F. App'x 117 (Ninth Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
352 F.3d 1222, 2003 U.S. App. LEXIS 25317, 2003 WL 22962231, Counsel Stack Legal Research, https://law.counselstack.com/opinion/raich-v-ashcroft-ca9-2003.